1. Home
  2. CTS vs MDXG Comparison

CTS vs MDXG Comparison

Compare CTS & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CTS Corporation

CTS

CTS Corporation

HOLD

Current Price

$44.44

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$7.01

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTS
MDXG
Founded
1896
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CTS
MDXG
Price
$44.44
$7.01
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$11.00
AVG Volume (30 Days)
207.8K
722.5K
Earning Date
02-03-2026
10-29-2025
Dividend Yield
0.36%
N/A
EPS Growth
3.07
N/A
EPS
1.98
0.27
Revenue
$531,522,000.00
$393,442,000.00
Revenue This Year
$5.73
$19.13
Revenue Next Year
$4.00
$2.11
P/E Ratio
$22.42
$26.21
Revenue Growth
3.61
14.77
52 Week Low
$34.02
$5.79
52 Week High
$54.12
$9.71

Technical Indicators

Market Signals
Indicator
CTS
MDXG
Relative Strength Index (RSI) 55.46 48.25
Support Level $43.62 $6.91
Resistance Level $44.74 $7.45
Average True Range (ATR) 1.12 0.25
MACD -0.09 0.00
Stochastic Oscillator 53.14 40.13

Price Performance

Historical Comparison
CTS
MDXG

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: